Cargando…
Biomarkers and clinical scoring systems in community-acquired pneumonia
Community-acquired pneumonia (CAP) is the third most common cause of death globally. Due to the complexity of CAP, it is widely accepted that, currently, clinical prognosis and diagnosis is inadequate for the assessment of the severity of the disease. With the aim to determining the initial treatmen...
Autores principales: | Karakioulaki, Meropi, Stolz, Daiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611198/ https://www.ncbi.nlm.nih.gov/pubmed/31333765 http://dx.doi.org/10.4103/atm.ATM_305_18 |
Ejemplares similares
-
Biomarkers in Pneumonia—Beyond Procalcitonin
por: Karakioulaki, Meropi, et al.
Publicado: (2019) -
Extracellular matrix remodelling in COPD
por: Karakioulaki, Meropi, et al.
Publicado: (2020) -
The Role of Atopy in COPD and Asthma
por: Karakioulaki, Meropi, et al.
Publicado: (2021) -
Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea—a prospective intervention study
por: Karakioulaki, Meropi, et al.
Publicado: (2021) -
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
por: Müller, Beat, et al.
Publicado: (2007)